Data / Form D filings / eGenesis, Inc.
eGenesis, Inc.: Form D filings
eGenesis, Inc., a biotechnology company in Cambridge, MA, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on February 27, 2024, reports $25.4 million sold of a $28.7 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 CAMBRIDGEPARK DR., SUITE 200, Cambridge, MA, 02140
- Phone
- (617) 939-3643
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1682809
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | New notice | $28,719,296 | $25,419,995 | $3,299,301 | 11 | Feb 13, 2024 | sec.gov |
| Mar 10, 2021 | New notice | $124,999,955 | $124,999,955 | 43 | Feb 26, 2021 | sec.gov | |
| Nov 14, 2019 | New notice | $100,000,000 | $100,000,000 | 20 | Nov 1, 2019 | sec.gov | |
| Mar 23, 2017 | New notice | $38,189,826 | $12,618,399 | $25,571,427 | 12 | Mar 13, 2017 | sec.gov |
| Aug 23, 2016 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 2 | Aug 8, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sarah Schlesinger | Director | |
| Mark Pruzanski | Director | |
| Brad Smith | Director | |
| Steven Gillis | Director | |
| Rahul Kakkar | Director | |
| Albert Wiegman | Director | |
| Julie Sunderland | Director | |
| Michael Curtis | Executive Officer, Director | |
| Jennifer Bergheiser | Executive Officer | |
| Paul Sekhri | Director | |
| Lucio Iannone | Director | |
| Kathleen Fanning | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 26, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what eGenesis, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.